u/pavel_kimani

Retitled to remove editorialising. Put the evidence in the body.

Came off after 83 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

the rodent data rodent evidence is solid, human evidence is not

reimbursement reality differs sharply

the BPC-157 literature looks promising but rodent-only

This is an urgent-care question wearing a forum question's clothes.

Adding to this: pentadecapeptide is doing more work than the comment implies.

research use only, no human protocols, no injection instructions

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

apotheke, receta, EMA — twenty-seven different answers

research use only, no human protocols, no injection instructions

This is correct. Tag your country.

EMA notices are different from national ones

tendon and rodent data literature in rodents is interesting

apotheke, receta, pharmacy — twenty-seven different answers

Half-life is about 168 hours, so steady state lands around week 14–5. Practical consequence: what you feel in week 1 is not what that dose does.

Strongly agree. Zero human controlled data.

the sequence literature looks promising but rodent-only

BPC pentadecapeptide is a naming problem, three things are called this

The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.

Spain here. Waited 10 months on a list, gave up, went private, and the total cost was roughly what I expected.